WO2001054735A3 - Eponges a base de collagene destinees a la reparation et a l'augmentation tissulaire - Google Patents

Eponges a base de collagene destinees a la reparation et a l'augmentation tissulaire Download PDF

Info

Publication number
WO2001054735A3
WO2001054735A3 PCT/US2001/002837 US0102837W WO0154735A3 WO 2001054735 A3 WO2001054735 A3 WO 2001054735A3 US 0102837 W US0102837 W US 0102837W WO 0154735 A3 WO0154735 A3 WO 0154735A3
Authority
WO
WIPO (PCT)
Prior art keywords
gel
augmentation
tissue repair
infused
sponges
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/002837
Other languages
English (en)
Other versions
WO2001054735A2 (fr
Inventor
Hanne Bentz
A Minerva Garcia
Jeffrey A Hubbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthogene Inc
Original Assignee
Orthogene Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthogene Inc filed Critical Orthogene Inc
Priority to AU2001234623A priority Critical patent/AU2001234623A1/en
Publication of WO2001054735A2 publication Critical patent/WO2001054735A2/fr
Publication of WO2001054735A3 publication Critical patent/WO2001054735A3/fr
Priority to US10/207,439 priority patent/US20030095993A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A61L27/3821—Bone-forming cells, e.g. osteoblasts, osteocytes, osteoprogenitor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3847—Bones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A61L27/3843—Connective tissue
    • A61L27/3852—Cartilage, e.g. meniscus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
    • A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/52—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Transplantation (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Vascular Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne une matrice d'éponge à base de collagène, comprenant une matière d'éponge adsorbable, un gel et un ingrédient actif. L'invention concerne également des procédés destinés à améliorer la réparation, la régénération ou l'augmentation tissulaire au moyen de cette éponge à base de collagène.
PCT/US2001/002837 2000-01-28 2001-01-26 Eponges a base de collagene destinees a la reparation et a l'augmentation tissulaire Ceased WO2001054735A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2001234623A AU2001234623A1 (en) 2000-01-28 2001-01-26 Gel-infused sponges for tissue repair and augmentation
US10/207,439 US20030095993A1 (en) 2000-01-28 2002-07-26 Gel-infused sponges for tissue repair and augmentation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17864600P 2000-01-28 2000-01-28
US60/178,646 2000-01-28

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US10/207,439 Continuation US20030095993A1 (en) 2000-01-28 2002-07-26 Gel-infused sponges for tissue repair and augmentation

Publications (2)

Publication Number Publication Date
WO2001054735A2 WO2001054735A2 (fr) 2001-08-02
WO2001054735A3 true WO2001054735A3 (fr) 2001-12-20

Family

ID=22653340

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/002837 Ceased WO2001054735A2 (fr) 2000-01-28 2001-01-26 Eponges a base de collagene destinees a la reparation et a l'augmentation tissulaire

Country Status (2)

Country Link
AU (1) AU2001234623A1 (fr)
WO (1) WO2001054735A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599515B1 (en) * 1995-01-16 2003-07-29 Baxter International Inc. Fibrin porous structure
US6965014B1 (en) 1996-01-16 2005-11-15 Baxter International Inc. Fibrin material and method for producing and using the same
US20140193468A1 (en) * 2001-03-23 2014-07-10 Histogenics Corporation Methods for preparation of neo-cartilage constructs
JP3646162B2 (ja) * 2001-07-04 2005-05-11 独立行政法人産業技術総合研究所 軟骨組織の再生用移植体
DE102005030614B4 (de) 2005-06-30 2014-05-08 Biotissue Ag Zellfreies Transplantat, dessen Verwendung, Verfahren zu dessen Herstellung, dabei hergestellte Matrix mit Gel und Verfahren zur Herstellung dieser Matrix mit Gel
US20070202084A1 (en) * 2005-12-14 2007-08-30 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
US20070196342A1 (en) * 2005-12-14 2007-08-23 Sadozai Khalid K Meniscal implant of hyaluronic acid derivatives for treatment of meniscal defects
CA2643083A1 (fr) * 2006-03-01 2007-09-13 Fmc Biopolymer As Mousse biodegradable
DE102006047346A1 (de) 2006-10-06 2008-04-10 Transtissue Technologies Gmbh Matrix-Gel-Transplantat ohne Zellen
US20090054984A1 (en) 2007-08-20 2009-02-26 Histogenics Corporation Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
EP2522376B1 (fr) * 2008-10-17 2020-01-08 Sofradim Production Procédé de préparation de matrice auto-adhésive pour la réparation de tissus
EP2370112B1 (fr) * 2008-11-24 2017-04-05 Bonus Cellora Ltd. Composition matricielle implantable dans laquelle des liposomes sont incorporés, et ses utilisations
US8969473B2 (en) 2009-02-21 2015-03-03 Sofradim Production Compounds and medical devices activated with solvophobic linkers
CN104159527B (zh) 2012-03-06 2017-04-12 弗罗桑医疗设备公司 包含止血糊剂的压力容器
JP6390873B2 (ja) 2013-06-21 2018-09-19 フェッローサン メディカル ディバイス エー／エス 減圧膨張させた乾燥組成物およびそれを保持するためのシリンジ
BR112016013322B1 (pt) 2013-12-11 2020-07-21 Ferrosan Medical Devices A/S métodos para preparação de uma composição seca e para reconstituir uma composição seca, composição seca, uso de uma composição seca, e, kit
BR112017007466B1 (pt) 2014-10-13 2021-03-02 Ferrosan Medical Devices A/S método para preparar uma composição seca, método para reconstituir a composição seca, pasta, composição seca, recipiente, kit homeostático, e, uso de uma composição seca
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
CA2986981A1 (fr) 2015-07-03 2017-01-12 Ferrosan Medical Devices A/S Seringue pour melanger deux composants et pour conserver un vide dans une condition de stockage
US11129790B2 (en) 2017-05-19 2021-09-28 Northeastern University Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
EP4321182A3 (fr) 2018-05-09 2024-05-29 Ferrosan Medical Devices A/S Procédé de préparation d'une composition hémostatique

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451397A (en) * 1981-11-30 1984-05-29 Centre Technique Du Cuir Method of preparing collagen products
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
FR2657352A1 (fr) * 1990-01-25 1991-07-26 France Etat Armement Nouveau produit biologique de remplacement du tissu conjonctif, a structure composite a base de collagene, et procede pour sa preparation.
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
WO1996025961A1 (fr) * 1995-02-22 1996-08-29 Ed Geistlich Söhne Ag Für Chemische Industrie Matrice extracellulaire resorbable pour la reconstruction du tissu cartilagineux
US5645849A (en) * 1993-11-03 1997-07-08 Clarion Pharmaceuticals, Inc. Hemostatic patch
WO1998040111A1 (fr) * 1997-03-07 1998-09-17 University College London Implant de tissus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4451397A (en) * 1981-11-30 1984-05-29 Centre Technique Du Cuir Method of preparing collagen products
US4703108A (en) * 1984-03-27 1987-10-27 University Of Medicine & Dentistry Of New Jersey Biodegradable matrix and methods for producing same
FR2657352A1 (fr) * 1990-01-25 1991-07-26 France Etat Armement Nouveau produit biologique de remplacement du tissu conjonctif, a structure composite a base de collagene, et procede pour sa preparation.
US5512301A (en) * 1992-05-01 1996-04-30 Amgen Inc. Collagen-containing sponges as drug delivery compositions for proteins
US5645849A (en) * 1993-11-03 1997-07-08 Clarion Pharmaceuticals, Inc. Hemostatic patch
WO1996025961A1 (fr) * 1995-02-22 1996-08-29 Ed Geistlich Söhne Ag Für Chemische Industrie Matrice extracellulaire resorbable pour la reconstruction du tissu cartilagineux
WO1998040111A1 (fr) * 1997-03-07 1998-09-17 University College London Implant de tissus

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9533069B2 (en) 2008-02-29 2017-01-03 Ferrosan Medical Devices A/S Device for promotion of hemostasis and/or wound healing
US9265858B2 (en) 2012-06-12 2016-02-23 Ferrosan Medical Devices A/S Dry haemostatic composition

Also Published As

Publication number Publication date
AU2001234623A1 (en) 2001-08-07
WO2001054735A2 (fr) 2001-08-02

Similar Documents

Publication Publication Date Title
WO2001054735A3 (fr) Eponges a base de collagene destinees a la reparation et a l'augmentation tissulaire
AU2051000A (en) Methods for soft tissue augmentation
AU5160500A (en) Apparatuses, methods and compositions for closing tissue puncture openings
AU2003277243A1 (en) Tissue mimicking elastography phantoms
WO2004021968A3 (fr) Solution destinee a une application ungueale et peri-ungueale
AU2002343561A1 (en) Composition and method for growing, protecting, and healing tissues and cells
AU2001249967A1 (en) Composition and methods for tissue preservation
AU2003251858A1 (en) Microbubble compositions, and methods for preparing and using same
AU2002232544A1 (en) Skin disinfectant applicator
AU2002229087A1 (en) Skin disinfectant applicator
AU2003266286A1 (en) Laser-based device for non-mechanical, three-dimensional trepanation during cornea transplants
MXPA02001613A (es) Material y metodos para incremento de tejido.
AU2003213367A1 (en) Base material for tissue regeneration, transplantation material and process for producing the same
AU2002222241A1 (en) Soft tissue implant
IL163128A (en) Method for isolating human tissue from olfactory neuroepithelium cells, uses thereof and method using the same
AU2003224321A1 (en) An assembly for use in orthopaedic surgery
AU2271400A (en) Composition, kit, method and device for hair treatment
AU2001248215A1 (en) Cosmetically active composition
AU5117400A (en) Tip structures, devices on their basis, and methods for their preparation
BRPI0209619B8 (pt) agente promotor de crescimento capilar
AU2003223003A1 (en) An assembly for use in orthopaedic surgery
ZA993035B (en) Surgical nail forceps.
WO2003084499A3 (fr) Preparations nettoyantes sous forme de gel contenant des derives d'amidon pregelatinises a reticulation transversale et des polyacrylates
AU2002220396A1 (en) Filler composition for soft tissue augmentation and reconstructive surgery
EP1368029A4 (fr) Procede et composition de rajeunissement des cellules, des tissus, des organes, des cheveux et des ongles

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 10207439

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP